SPERO THERAPEUTICS, INC.: cashflow_operating
| Value | {"amount": -28959000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-12-31 |
| Status | superseded |
| Entity | SPERO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:24:43.455605+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cc81ffef-cee3-4432-8e6b-73aea0b28993
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-007402Retrieved: 2026-08-19T17:24:43.455605+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001701108/cashflow-operating/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cc81ffef-cee3-4432-8e6b-73aea0b28993
History
- no predecessors — first report